DiscoverNeuroFlex PodcastNick Kadysh: The Future of MDMA Therapy | Episode 210
Nick Kadysh: The Future of MDMA Therapy | Episode 210

Nick Kadysh: The Future of MDMA Therapy | Episode 210

Update: 2023-03-08
Share

Description

Nick Kadysh is the Founder of PharmAla Biotech, dedicated to the manufacture of MDMA and MDXX class molecules for pharmaceutical research.

He spent the majority of his career helping companies navigate complex regulatory risk in Healthcare. After a career in Government at the Federal and Provincial levels, he has served as Head of Corporate Affairs at JUUL Labs Canada, Government Affairs & Public Leader at GE Healthcare and Director of Public Affairs for Red Bull Canada. 

https://pharmala.ca



Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Nick Kadysh: The Future of MDMA Therapy | Episode 210

Nick Kadysh: The Future of MDMA Therapy | Episode 210

Toby Pasman